Kim H, Oh Y, Moon S, Oh J, Kim J, Lee S
J Ginseng Res. 2025; 49(2):166-178.
PMID: 40061481
PMC: 11889375.
DOI: 10.1016/j.jgr.2024.11.004.
Naiditch H, Betts M, Larman H, Levi M, Rosenberg A
Front Immunol. 2025; 15:1376654.
PMID: 40012912
PMC: 11861071.
DOI: 10.3389/fimmu.2024.1376654.
Alshahrani M, Aldahhan R, Macadato N, Alkhalifah Z, Tahan M, Alnimr A
Saudi J Med Med Sci. 2025; 13(1):39-46.
PMID: 39936001
PMC: 11809754.
DOI: 10.4103/sjmms.sjmms_282_24.
Salamony A, Abdelsalam M, Elguindy N, Roshdy W, Youssef A, Shamikh Y
Curr Microbiol. 2025; 82(3):122.
PMID: 39918738
DOI: 10.1007/s00284-025-04095-3.
Malaspina P, Jodice C, Ciminelli B, Biancolella M, Colona V, Latini A
Hum Genomics. 2025; 19(1):7.
PMID: 39885568
PMC: 11780896.
DOI: 10.1186/s40246-025-00719-8.
Reflections on COVID-19: A Literature Review of SARS-CoV-2 Testing.
Lau C, Oh H, Aw T
Vaccines (Basel). 2025; 13(1).
PMID: 39852788
PMC: 11768752.
DOI: 10.3390/vaccines13010009.
Persistence of SARS-CoV-2 Antibodies for a Year Following SARS-CoV-2 Vaccinations (BBV152 and ChAdOx1 nCoV-19).
Dwivedi T, Raj A, Das N, Gupta R, Bhatnagar S, Mohan A
Indian J Clin Biochem. 2025; 40(1):111-120.
PMID: 39835239
PMC: 11741955.
DOI: 10.1007/s12291-023-01149-w.
Seroprevalence of SARS-CoV-2 in wet market workers in Dhaka, Bangladesh in 2022.
Rahman M, Alam A, Sarkar S, Khan M, Mangtani P, Butt S
IJID Reg. 2025; 14():100497.
PMID: 39810749
PMC: 11732135.
DOI: 10.1016/j.ijregi.2024.100497.
Unraveling the impact of SARS-CoV-2 mutations on immunity: insights from innate immune recognition to antibody and T cell responses.
Bayarri-Olmos R, Sutta A, Rosbjerg A, Mortensen M, Helgstrand C, Nielsen P
Front Immunol. 2024; 15:1412873.
PMID: 39720734
PMC: 11666439.
DOI: 10.3389/fimmu.2024.1412873.
Co-immunization with spike and nucleocapsid based DNA vaccines for long-term protective immunity against SARS-CoV-2 Omicron.
Pinto P, Timis J, Chuensirikulchai K, Li Q, Lu H, Maule E
NPJ Vaccines. 2024; 9(1):252.
PMID: 39702529
PMC: 11659323.
DOI: 10.1038/s41541-024-01043-3.
Prevalence of SARS-CoV-2 antibodies at the University hospital Heidelberg and correlation with SARS-CoV-2 incidence.
Bundschuh C, Weidner N, Scholz T, Parthe S, Jost L, Gossnitzer E
Heliyon. 2024; 10(22):e40282.
PMID: 39641027
PMC: 11617710.
DOI: 10.1016/j.heliyon.2024.e40282.
Safety and Immunogenicity of Intranasal Razi Cov Pars as a COVID-19 Booster Vaccine in Adults: Promising Results from a Groundbreaking Clinical Trial.
Fallah Mehrabadi M, Hajimoradi M, Es-Haghi A, Kalantari S, Noofeli M, Mokarram A
Vaccines (Basel). 2024; 12(11).
PMID: 39591158
PMC: 11598910.
DOI: 10.3390/vaccines12111255.
Neutralizing Antibody-Mediated Protection from Prior Delta Variant Infection Against Omicron BA.5 Sub-Lineage Reinfection One Year Later: A Prospective Cohort Study.
Zhang S, Wang Y, Xu G, Dong C, Tian H, Li C
Vaccines (Basel). 2024; 12(11).
PMID: 39591114
PMC: 11598881.
DOI: 10.3390/vaccines12111211.
Immune evasion after SARS-CoV-2 Omicron BA.5 and XBB.1.9 endemic observed from Guangdong Province, China from 2022 to 2023.
Zhang H, Li B, Sun J, Zou L, Yi L, Lin H
Virol J. 2024; 21(1):298.
PMID: 39568037
PMC: 11577657.
DOI: 10.1186/s12985-024-02573-x.
Absolute concentration estimation of COVID-19 convalescent and post-vaccination IgG antibodies.
Klegerman M, Peng T, Seferovich I, Rahbar M, Hessabi M, Tahanan A
PLoS One. 2024; 19(11):e0311777.
PMID: 39485748
PMC: 11530011.
DOI: 10.1371/journal.pone.0311777.
Development and Evaluation of In-House ELISAs for the Detection of SARS-CoV-2-Specific Antibodies in COVID-19 Patients in Sri Lanka.
Pathirana S, Deepachandi B, Gunasekara P, Fernando N, Perera I, Gangani D
Int J Microbiol. 2024; 2024:1331067.
PMID: 39346702
PMC: 11427722.
DOI: 10.1155/2024/1331067.
Seroprevalence of SARS-CoV-2 infection in pediatric patients in a tertiary care hospital setting.
Pattanakitsakul P, Pongpatipat C, Setthaudom C, Kunakorn M, Sahakijpicharn T, Visudtibhan A
PLoS One. 2024; 19(9):e0310860.
PMID: 39316628
PMC: 11421809.
DOI: 10.1371/journal.pone.0310860.
The roles of CD4 T cell help, sex, and dose in the induction of protective CD8 T cells against a lethal poxvirus by mRNA-LNP vaccines.
Kafle S, Montoya B, Tang L, Tam Y, Muramatsu H, Pardi N
Mol Ther Nucleic Acids. 2024; 35(3):102279.
PMID: 39188304
PMC: 11345529.
DOI: 10.1016/j.omtn.2024.102279.
Immune responses in COVID-19 patients: Insights into cytokine storms and adaptive immunity kinetics.
Zhang J
Heliyon. 2024; 10(14):e34577.
PMID: 39149061
PMC: 11325674.
DOI: 10.1016/j.heliyon.2024.e34577.
Comprehensive Review of COVID-19: Epidemiology, Pathogenesis, Advancement in Diagnostic and Detection Techniques, and Post-Pandemic Treatment Strategies.
Chung Y, Lam C, Tan P, Tsang H, Wong S
Int J Mol Sci. 2024; 25(15).
PMID: 39125722
PMC: 11312261.
DOI: 10.3390/ijms25158155.
